Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | BLVRB | P30043 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3395948 | 0.86 | MEN1 (0.70) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL9064961 | 0.85 | MEN1 (0.48) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL1624756 | 0.83 | MEN1 (0.70) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL26730466 | 0.83 | MEN1 (0.70) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL3385330 | 0.83 | MEN1 (0.70) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL20132516 | 0.81 | KDM4E (0.44) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL10930328 | 0.81 | MEN1 (0.68) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL15391204 | 0.81 | HSD17B10 (0.41) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL3396994 | 0.81 | TSHR (0.52) | ALDH1A1HSD17B10HPGDMEN1KMT2A | |
| SCHEMBL6632160 | 0.79 | MAPT (0.57) | ALDH1A1HSD17B10HPGDKMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276953-A1 | SMALL MOLECULE SIRTUIN INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-09-04 | — | — | US | disclosed |
| CN-101965331-B | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL IND LTD | 2014-04-16 | — | — | CN | disclosed |
| US-8367857-B2 | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| CN-101965331-A | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL IND LTD | 2011-02-02 | — | — | CN | disclosed |
| US-20100312000-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
| EP-2248800-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | Nissan Chemical Industries, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-6875764-B1 | Urea and thiourea compounds useful for treatment of coccidiosis | NEW PHARMA RESEARCH SWEDEN AB (SE) | 2005-04-05 | — | — | US | disclosed |
| EP-1224165-A1 | NOVEL COMPOUNDS | New Pharma Research Sweden AB (SE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001030749-A1 | NOVEL COMPOUNDS | NEW PHARMA RESEARCH SWEDEN AB (SE) | 2001-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100312000-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | CBS, CTH, TST | ALDH1A1 820/4885HSD17B10 1193/4885HPGD 2416/4885 |
| US-20250276953-A1 | SMALL MOLECULE SIRTUIN INHIBITORS AND USES THEREOF | SIRT6, SIRT2, SIRT1 | ALDH1A1 2313/4885HSD17B10 857/4885HPGD 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.